The study of serum muscarinic acetylcholine receptor subtype 3 (m3AChR)-Specific autoantibodies level in rheumatoid arthritis patients with secondary sjogren syndrome.

Fakher HE, El Gazzar NM, Mabrouk MM, Nada DW

Open source

DOI
10.1186/s41927-023-00368-1
Published
2023 Dec 18
Container
BMC rheumatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s41927-023-00368-1,
  title = {The study of serum muscarinic acetylcholine receptor subtype 3 (m3AChR)-Specific autoantibodies level in rheumatoid arthritis patients with secondary sjogren syndrome.},
  author = {Fakher HE and El Gazzar NM and Mabrouk MM and Nada DW},
  year = {2023},
  journal = {BMC rheumatology},
  doi = {10.1186/s41927-023-00368-1},
  url = {https://doi.org/10.1186/s41927-023-00368-1}
}

RIS

TY  - JOUR
TI  - The study of serum muscarinic acetylcholine receptor subtype 3 (m3AChR)-Specific autoantibodies level in rheumatoid arthritis patients with secondary sjogren syndrome.
AU  - Fakher HE
AU  - El Gazzar NM
AU  - Mabrouk MM
AU  - Nada DW
PY  - 2023
JO  - BMC rheumatology
DO  - 10.1186/s41927-023-00368-1
UR  - https://doi.org/10.1186/s41927-023-00368-1
ER  - 

APA

HE, F., NM, E. G., MM, M., & DW, N. (2023). The study of serum muscarinic acetylcholine receptor subtype 3 (m3AChR)-Specific autoantibodies level in rheumatoid arthritis patients with secondary sjogren syndrome.. BMC rheumatology. https://doi.org/10.1186/s41927-023-00368-1

Source records